HT
HRTX icon

HAP Trading’s Heron Therapeutics HRTX Stock Holding History

HAP Trading’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,400
Closed -$5K – 2475
2021
Q4 		$5K Sell
11,400
-4,200
-27% -$42.9K ﹤0.01% 2223
2021
Q3 		$7K Buy
+15,600
New +$190K ﹤0.01% 2105
2020
Q2 		– Sell
-21,900
Closed -$11K – 1790
2020
Q1 		$11K Buy
+21,900
New +$412K ﹤0.01% 1000
2019
Q4 		– Sell
-10,400
Closed -$11K – 1337
2019
Q3 		$11K Buy
+10,400
New +$191K ﹤0.01% 1039
2019
Q1 		– Sell
-10,200
Closed -$5K – 1213
2018
Q4 		$5K Sell
10,200
-90,600
-90% -$2.49M ﹤0.01% 1015
2018
Q3 		$16K Sell
100,800
-1,700
-2% -$63.3K ﹤0.01% 789
2018
Q2 		$335K Buy
102,500
+700
+0.7% +$22.3K 0.02% 384
2018
Q1 		$171K Buy
+101,800
New +$2.31M 0.01% 474
2017
Q1 		– Sell
-170,000
Closed -$11K – 1153
2016
Q4 		$11K Buy
+170,000
New +$2.67M ﹤0.01% 834
2016
Q3 		– Sell
-17,800
Closed -$24K – 1171
2016
Q2 		$24K Buy
17,800
+7,600
+75% +$148K ﹤0.01% 698
2016
Q1 		$11K Sell
10,200
-296,800
-97% -$5.86M ﹤0.01% 672
2015
Q4 		$322K Buy
307,000
+278,400
+973% +$7.44M 0.02% 431
2015
Q3 		$15K Buy
+28,600
New +$953K ﹤0.01% 852
2015
Q2 		– Sell
-385,000
Closed -$164K – 1066
2015
Q1 		$164K Buy
+385,000
New +$4.34M 0.01% 468

Other funds holding HRTX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

HAP Trading's HRTX Position: Q2 2020 in Review

HAP Trading sold out of Heron Therapeutics (HRTX) in Q2 2020, closing a stake of 39,115 shares — an estimated $643K sold.

HAP Trading first reported a position in HRTX in Q1 2015 and held it in 9 quarters. The position peaked at $3.22M in Q4 2015. 190 funds tracked by Wall St. Rank hold HRTX as of Q2 2020.

  • HAP Trading reported no remaining Heron Therapeutics position as of Q2 2020 after selling out during the quarter.
  • HAP Trading sold 39,115 Heron Therapeutics shares in Q2 2020, an estimated $643K.
  • HAP Trading first reported a position in Heron Therapeutics in Q1 2015 and held it in 9 quarters.
  • HAP Trading's Heron Therapeutics position peaked at $3.22M in Q4 2015.
  • 190 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2020.

Based on HAP Trading's 13F filing for Q2 2020, filed 10 Aug 2020.